{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:47:13Z","timestamp":1782604033210,"version":"3.54.5"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.beem.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T19:48:30Z","timestamp":1529351310000},"page":"621-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Parathyroid hormone independent hypercalcemia in adults"],"prefix":"10.1016","volume":"32","author":[{"given":"Jens","family":"Bollerslev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2018.06.005_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.06.005_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0221-8747(79)90021-3","article-title":"Equilibrium and disequilibrium hypercalcemia. New light on an old concept","volume":"1","author":"Parfitt","year":"1979","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1016\/j.beem.2018.06.005_bib3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(97)12331-5","article-title":"Electrolyte quintet: calcium","volume":"352","author":"Bushinsky","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2018.06.005_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2003.05.002","article-title":"Misconceptions (3): calcium leaves bone only by resorption and enters only by formation","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bone.2003.06.001","article-title":"Large calcium fluxes that are not related to remodeling exist","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/02813432.2013.861152","article-title":"Long-term follow-up of patients with elevated serum calcium concentrations in Swedish primary care","volume":"31","author":"Dalemo","year":"2013","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.beem.2018.06.005_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.HYP.34.3.484","article-title":"Serum calcium and cardiovascular risk factors and diseases: the Tromso study","volume":"34","author":"Jorde","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2018.06.005_bib8","first-page":"2149","article-title":"Serum calcium and survival in a large health screening program","volume":"81","author":"Leifsson","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2018.06.005_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/jc.2007-0600","article-title":"Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity","volume":"93","author":"Siilin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib13","first-page":"436","article-title":"Prevalence of hypercalcaemia in normal and in hospital populations","volume":"45","author":"Frolich","year":"1998","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.beem.2018.06.005_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0889-8529(18)30417-1","article-title":"Hypercalcemia","volume":"17","author":"Klee","year":"1988","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2018.06.005_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","article-title":"Interpretation of serum calcium in patients with abnormal serum proteins","volume":"4","author":"Payne","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.beem.2018.06.005_bib16","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","article-title":"The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism","volume":"97","author":"Ong","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib17","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)","author":"Lundstam","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jc.2014-3441","article-title":"Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism","volume":"100","author":"Lundstam","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib19","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib20","first-page":"863","article-title":"Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on","volume":"161","author":"Elvius","year":"1995","journal-title":"Eur J Surg"},{"key":"10.1016\/j.beem.2018.06.005_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1026597816193","article-title":"Hypercalcemia of malignancy","volume":"1","author":"Grill","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2018.06.005_bib22","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.beem.2018.06.005_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.beem.2018.06.005_bib24","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cam4.749","article-title":"Prevalence of hypercalcemia among cancer patients in the United States","volume":"5","author":"Gastanaga","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.beem.2018.06.005_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.canep.2015.10.012","article-title":"Prevalence of hypercalcemia of malignancy among cancer patients in the UK: analysis of the Clinical Practice Research Datalink database","volume":"39","author":"Jick","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.beem.2018.06.005_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/physrev.00031.2015","article-title":"Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases","volume":"96","author":"Martin","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.beem.2018.06.005_bib27","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2018.06.005_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib29","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-13-0136","article-title":"Autosomal dominant osteopetrosis revisited: lessons from recent studies","volume":"169","author":"Bollerslev","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/er.2010-0006","article-title":"Osteoclast activity and subtypes as a function of physiology and pathology\u2013implications for future treatments of osteoporosis","volume":"32","author":"Henriksen","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2018.06.005_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.3291","article-title":"Autocrine and paracrine regulation of the murine skeleton by osteocyte-derived parathyroid hormone-related protein","volume":"33","author":"Ansari","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-55-2-219","article-title":"Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity","volume":"55","author":"Stewart","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(92)90360-9","article-title":"Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods","volume":"13","author":"Christiansen","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.03.020","article-title":"Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism","volume":"41","author":"Dempster","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S8756-3282(00)00260-X","article-title":"Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment","volume":"26","author":"Steiniche","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/me.2007-0274","article-title":"Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH\/PTHrP receptor","volume":"22","author":"Dean","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib38","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/1078-0432.CCR-04-2531","article-title":"Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors","volume":"11","author":"Onuma","year":"2005","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.beem.2018.06.005_bib39","first-page":"801","article-title":"Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy","volume":"76","author":"Schilling","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib40","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib41","first-page":"249","article-title":"Clinical characteristics, causes and survival in 115 cancer patients with parathyroid hormone related protein-mediated hypercalcemia","volume":"24","author":"Jin","year":"2017","journal-title":"J\u00a0Bone Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib42","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.clml.2017.12.006","article-title":"Mechanisms of hypercalcemia in non-hodgkin lymphoma and associated outcomes: a retrospective review","volume":"18","author":"Shallis","year":"2018","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.beem.2018.06.005_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajcp\/105.4.487","article-title":"The humoral hypercalcemia of benignancy. A newly appreciated syndrome","volume":"105","author":"Knecht","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beem.2018.06.005_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11914-017-0397-5","article-title":"Myeloma and bone disease","volume":"15","author":"Panaroni","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.beem.2018.06.005_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","article-title":"Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007)","volume":"129","author":"Yong","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl:C275\u20139","key":"10.1016\/j.beem.2018.06.005_bib46","article-title":"Clinical analysis of 64 patients with lung-cancer-associated hypercalcemia","volume":"11","author":"Li","year":"2015","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.beem.2018.06.005_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JTO.0000000000000051","article-title":"Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13","volume":"9","author":"Katakami","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.beem.2018.06.005_bib48","first-page":"1779","article-title":"Hypercalcemia of malignancy and new treatment options","volume":"11","author":"Sternlicht","year":"2015","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.beem.2018.06.005_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.beem.2018.06.005_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.20774","article-title":"Role of osteoblast suppression in multiple myeloma","volume":"98","author":"Stewart","year":"2006","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.beem.2018.06.005_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.beem.2018.06.005_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(18)30075-5","article-title":"Denosumab for myeloma bone disease: ready for prime time?","volume":"19","author":"Dimopoulos","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2018.06.005_bib53","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol"},{"issue":"Suppl:S57\u201373","key":"10.1016\/j.beem.2018.06.005_bib54","article-title":"The vitamin D hormone and its nuclear receptor: molecular actions and disease states","volume":"154","author":"Haussler","year":"1997","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2003.11.017","article-title":"Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase","volume":"215","author":"Hewison","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1525-139X.2007.00302.x","article-title":"Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3)","volume":"20","author":"Jones","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/j.beem.2018.06.005_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2018.06.005_bib58","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European society of endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1359\/jbmr.2000.15.2.228","article-title":"1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease","volume":"15","author":"Menaa","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib60","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/boneres.2016.30","article-title":"Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts","volume":"4","author":"Zarei","year":"2016","journal-title":"Bone Res."},{"key":"10.1016\/j.beem.2018.06.005_bib61","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1359\/jbmr.060714","article-title":"Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast","volume":"21","author":"Baldock","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib63","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1359\/JBMR.040604","article-title":"1 alpha,25 dihydroxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways","volume":"19","author":"Kondo","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220819","article-title":"Twist on a classic: vitamin D and hypercalcaemia of malignancy","volume":"2017","author":"Osorio","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2018.06.005_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08880010701774033","article-title":"1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma","volume":"25","author":"Hibi","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.beem.2018.06.005_bib67","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(19870501)59:9<1543::AID-CNCR2820590902>3.0.CO;2-L","article-title":"Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia","volume":"59","author":"Mudde","year":"1987","journal-title":"Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.beem.2018.06.005_bib68","doi-asserted-by":"crossref","first-page":"V20","DOI":"10.1359\/jbmr.07s214","article-title":"Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response","volume":"22","author":"Adams","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/EJE-17-0938","article-title":"Hypercalcemia associated with cosmetic injections: a systematic review","volume":"178","author":"Tachamo","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib70","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI101084","article-title":"Blood chemical changes in boeck's sarcoid with particular reference to protein, calcium and phosphatase values","volume":"18","author":"Harrell","year":"1939","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.06.005_bib71","first-page":"113","article-title":"Calcium and vitamin D metabolism in sarcoidosis","volume":"30","author":"Baughman","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.beem.2018.06.005_bib72","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-60-5-960","article-title":"Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis","volume":"60","author":"Adams","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib73","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.161.4.755","article-title":"Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis","volume":"161","author":"Adams","year":"1985","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.beem.2018.06.005_bib74","doi-asserted-by":"crossref","first-page":"d7505","DOI":"10.1136\/bmj.d7505","article-title":"Cod liver oil and tuberculosis","volume":"343","author":"Green","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2018.06.005_bib75","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.4049\/jimmunol.178.11.7190","article-title":"IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37","volume":"178","author":"Martineau","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beem.2018.06.005_bib76","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib77","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jbmr.3296","article-title":"Hypercalcemic disorders in children","volume":"32","author":"Stokes","year":"2017","journal-title":"J\u00a0Bone Miner Res - Off J Am Soc Bone and Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib78","doi-asserted-by":"crossref","first-page":"e6017","DOI":"10.1097\/MD.0000000000006017","article-title":"Hyperthyroidism-associated hypercalcemic crisis: a case report and review of the literature","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beem.2018.06.005_bib79","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/0004-2730000003311","article-title":"The multiple effects of thyroid disorders on bone and mineral metabolism","volume":"58","author":"Cardoso","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.06.005_bib80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2796.1992.tb00636.x","article-title":"Hypercalcaemia in Addison's disease: calciotropic hormone profile and bone histology","volume":"232","author":"Montoli","year":"1992","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.06.005_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2265.1999.00625.x","article-title":"Addison's disease in Africa\u2013a teaching hospital experience","volume":"50","author":"Soule","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.06.005_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208657","article-title":"Phaeochromocytoma with hypercortisolism and hypercalcaemia","volume":"2015","author":"Edafe","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.beem.2018.06.005_bib83","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1442-2042.2010.02555.x","article-title":"Parathyroid hormone-related peptide-producing non-familial pheochromocytoma in a child","volume":"17","author":"Takeda","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.beem.2018.06.005_bib84","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-65-3-429","article-title":"Hypercalcemia of thyrotoxicosis","volume":"65","author":"Baxter","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.06.005_bib85","first-page":"515","article-title":"Schwartz Sorensen N. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism","volume":"85","author":"Mosekilde","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.beem.2018.06.005_bib86","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI108497","article-title":"Direct stimulation of bone resorption by thyroid hormones","volume":"58","author":"Mundy","year":"1976","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.06.005_bib87","first-page":"566","article-title":"Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function","volume":"84","author":"Mosekilde","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.beem.2018.06.005_bib88","first-page":"743","article-title":"Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: chemical quantities in serum and urine","volume":"87","author":"Mosekilde","year":"1978","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.beem.2018.06.005_bib89","first-page":"751","article-title":"Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: bone histomorphometry","volume":"87","author":"Mosekilde","year":"1978","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.beem.2018.06.005_bib90","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJM198205133061903","article-title":"Calcium homeostasis in immobilization: an example of resorptive hypercalciuria","volume":"306","author":"Stewart","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib91","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1359\/jbmr.1998.13.10.1594","article-title":"The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects","volume":"13","author":"Zerwekh","year":"1998","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib92","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2010-0608","article-title":"Stand up!","volume":"95","author":"Rubin","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib93","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1210\/jc.2013-4205","article-title":"Using denosumab to treat immobilization hypercalcemia in a post-acute care patient","volume":"99","author":"Booth","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib94","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","article-title":"Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss","volume":"95","author":"Gaudio","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib95","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.376","article-title":"Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5","volume":"26","author":"Frost","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2018.06.005_bib96","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-17-0920","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: novel anabolic treatments for osteoporosis","volume":"178","author":"Canalis","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib97","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/imj.12269","article-title":"Prolonged vitamin D intoxication: presentation, pathogenesis and progress","volume":"43","author":"Bell","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.beem.2018.06.005_bib98","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/bcp.13573","article-title":"A\u00a0review of the growing risk of vitamin D toxicity from inappropriate practice","author":"Taylor","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.beem.2018.06.005_bib99","first-page":"4547","article-title":"Scientific opinion on dietary reference values for vitamin D","volume":"14","author":"EFSA Panel on Dietetic Products NaAN","year":"2016","journal-title":"EFSA"},{"key":"10.1016\/j.beem.2018.06.005_bib100","article-title":"Vitamin D intoxication caused by drugs bought online. Sky high daily dosage for six months resulted in severe hypercalcemia","volume":"112","author":"Mannheimer","year":"2015","journal-title":"Lakartidningen"},{"key":"10.1016\/j.beem.2018.06.005_bib101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2017.08.004","article-title":"How much is too much? Two contrasting cases of excessive vitamin D supplementation","volume":"473","author":"Kim","year":"2017","journal-title":"Clin Chim Acta - Int J Clin Chem"},{"key":"10.1016\/j.beem.2018.06.005_bib102","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJMc063341","article-title":"Dietary supplement-induced vitamin D intoxication","volume":"357","author":"Klontz","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJM200107053450115","article-title":"Vitamin D intoxication associated with an over-the-counter supplement","volume":"345","author":"Koutkia","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"86","key":"10.1016\/j.beem.2018.06.005_bib104","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5414\/CN108904","article-title":"The other side of vitamin D therapy: a case series of acute kidney injury due to malpractice-related vitamin D intoxication","volume":"2016","author":"Wani","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.beem.2018.06.005_bib105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cen.12836","article-title":"Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency","volume":"83","author":"Kaur","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib106","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ki.2013.230","article-title":"The case: renal failure in a bodybuilder athlete. Diagnosis: nephrocalcinosis secondary to exogenous vitamin D intoxication","volume":"85","author":"Liborio","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2018.06.005_bib107","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","article-title":"Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety","volume":"69","author":"Vieth","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2018.06.005_bib108","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000441-198205000-00008","article-title":"Vitamin A toxicity and hypercalcemia","volume":"283","author":"Ragavan","year":"1982","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.beem.2018.06.005_bib109","first-page":"777","article-title":"Bone resorption activity of all-trans retinoic acid is independent of vitamin D in rats","volume":"133","author":"Rohde","year":"2003","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.beem.2018.06.005_bib110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ar.1091580408","article-title":"Alpharadiographic and histological observations on the skeletal effects of hypervitaminoses A and D in the rat","volume":"158","author":"Belanger","year":"1967","journal-title":"Anat Rec"},{"key":"10.1016\/j.beem.2018.06.005_bib111","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcn\/83.2.191","article-title":"The acute and chronic toxic effects of vitamin A","volume":"83","author":"Penniston","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2018.06.005_bib112","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.2.4678.535","article-title":"Effects of hypervitaminosis A on foetal mouse bones cultivated in\u00a0vitro; preliminary communication","volume":"2","author":"Fell","year":"1950","journal-title":"Br Med J"},{"key":"10.1016\/j.beem.2018.06.005_bib113","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.1983.03340140069034","article-title":"Hypercalcemia associated with oral isotretinoin in the treatment of severe acne","volume":"250","author":"Valentic","year":"1983","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.06.005_bib114","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0609.1994.tb01878.x","article-title":"Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia: case report","volume":"53","author":"Suzumiya","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beem.2018.06.005_bib115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7326\/0003-4819-80-1-44","article-title":"Hypercalcemia and skeletal effects in chronic hypervitaminosis A","volume":"80","author":"Frame","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.06.005_bib116","first-page":"424712","article-title":"Case of hypercalcemia secondary to hypervitaminosis a in a 6-year-old boy with autism","volume":"2011","author":"Vyas","year":"2011","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.beem.2018.06.005_bib117","series-title":"Endotext","article-title":"Approach to hypercalcemia","author":"Goltzman","year":"2000"},{"key":"10.1016\/j.beem.2018.06.005_bib118","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.amjmed.2011.05.009","article-title":"Half a century of hydrochlorothiazide: facts, fads, fiction, and follies","volume":"124","author":"Messerli","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib119","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM197104152841506","article-title":"Thiazide-induced hypercalcemia","volume":"284","author":"Duarte","year":"1971","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib120","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.06.005_bib121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/endo.134.1.7506210","article-title":"Parathyroid hormone and hydrochlorothiazide increase calcium transport by the luminal membrane of rabbit distal nephron segments through different pathways","volume":"134","author":"Lajeunesse","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2018.06.005_bib122","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00198-008-0612-4","article-title":"Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons","volume":"19","author":"Ott","year":"2008","journal-title":"Osteopor Int"},{"key":"10.1016\/j.beem.2018.06.005_bib123","doi-asserted-by":"crossref","first-page":"L27","DOI":"10.1210\/jc.2014-4065","article-title":"Letter to the editor: thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism","volume":"100","author":"Yacobi-Bach","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.06.005_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.07.044","article-title":"Incidence and clinical spectrum of thiazide-associated hypercalcemia","volume":"120","author":"Wermers","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2018.06.005_bib125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semnephrol.2011.09.008","article-title":"Diuretics and disorders of calcium homeostasis","volume":"31","author":"Grieff","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.beem.2018.06.005_bib126","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.06.005_bib127","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.1973.03220080043012","article-title":"Rapid estrogen-induced hypercalcemia","volume":"223","author":"Swaroop","year":"1973","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.06.005_bib128","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/1097-0142(196909)24:3<610::AID-CNCR2820240328>3.0.CO;2-4","article-title":"Hypercalcemia associated with estrogen administration in patients with breast carcinoma","volume":"24","author":"Beckett","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2018.06.005_bib129","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1172\/JCI111753","article-title":"Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells","volume":"75","author":"Valentin-Opran","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2018.06.005_bib130","first-page":"608585","article-title":"Letrozole induced hypercalcemia in a patient with breast cancer","volume":"2014","author":"Ipekci","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.beem.2018.06.005_bib131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9610(81)90174-4","article-title":"Hypercalcemia induced by tamoxifen","volume":"141","author":"O'Connell","year":"1981","journal-title":"Am J Surg"},{"key":"10.1016\/j.beem.2018.06.005_bib132","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/1097-0142(19810615)47:12<2803::AID-CNCR2820471208>3.0.CO;2-A","article-title":"Tamoxifen-induced hypercalcemia in breast cancer","volume":"47","author":"Legha","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2018.06.005_bib133","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jama.1962.03050390039012b","article-title":"Acute fatal hypercalcemia. A complication in estrogen therapy of metastatic breast cancer","volume":"181","author":"Kleinfeld","year":"1962","journal-title":"Jama"},{"key":"10.1016\/j.beem.2018.06.005_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-9-1-1","article-title":"Hypercalcemic syndrome associated with androgenic and estrogenic therapy","volume":"9","author":"Herrmann","year":"1949","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2018.06.005_bib135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/pgmj.71.831.28","article-title":"Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism","volume":"71","author":"Hutchesson","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.beem.2018.06.005_bib136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.2930370104","article-title":"Malignancy and concomitant primary hyperparathyroidism","volume":"37","author":"Strodel","year":"1988","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.beem.2018.06.005_bib137","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S8756-3282(02)00685-3","article-title":"Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in\u00a0vitro and enhances breast cancer metastasis to bone in\u00a0vivo","volume":"30","author":"Guise","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.beem.2018.06.005_bib138","series-title":"Humoral hypercalcemia of malignancy: the case for parathyroid hormone-related protein, with caveats","author":"Singh","year":"2016"},{"key":"10.1016\/j.beem.2018.06.005_bib139","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","article-title":"Narrative review: furosemide for hypercalcemia: an unproven yet common practice","volume":"149","author":"LeGrand","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.06.005_bib140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jcem-57-4-819","article-title":"The sensitivity of isolated osteoclasts to morphological transformation by calcitonin","volume":"57","author":"Chambers","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib141","doi-asserted-by":"crossref","first-page":"F1337","DOI":"10.1152\/ajprenal.00273.2015","article-title":"Ways of calcium reabsorption in the kidney","volume":"310","author":"Moor","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.beem.2018.06.005_bib142","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2018.06.005_bib143","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2014-1001","article-title":"Denosumab for treatment of hypercalcemia of malignancy","volume":"99","author":"Hu","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib144","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-156-12-201206190-00026","article-title":"Denosumab for tumor-induced hypercalcemia complicated by renal failure","volume":"156","author":"Bech","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2018.06.005_bib145","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.clml.2014.07.005","article-title":"Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction","volume":"14","author":"Cicci","year":"2014","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.beem.2018.06.005_bib146","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jcem-52-1-111","article-title":"Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man","volume":"52","author":"Hahn","year":"1981","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.06.005_bib147","doi-asserted-by":"crossref","first-page":"G92","DOI":"10.1152\/ajpgi.00317.2006","article-title":"Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6","volume":"292","author":"Huybers","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.beem.2018.06.005_bib148","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0885066613507530","article-title":"Hypercalcemia in the intensive care unit: a review of pathophysiology, diagnosis, and modern therapy","volume":"30","author":"Maier","year":"2015","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.beem.2018.06.005_bib149","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/JPEM.2006.19.2.169","article-title":"Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis","volume":"19","author":"Atabek","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metabol - JPEM"},{"key":"10.1016\/j.beem.2018.06.005_bib150","first-page":"e122","article-title":"Comparison of oral alendronate versus prednisolone in treatment of infants with vitamin D intoxication","volume":"101","author":"Sezer","year":"2012","journal-title":"Acta Paediatr (Oslo, Norway : 1992)"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:34Z","timestamp":1761497614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1521690X18300873"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.005","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid hormone independent hypercalcemia in adults","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}